Biomodels, a preclinical CRO, conducts predictive and translational studies for biotechnology and pharmaceutical companies in the areas of inflammatory and autoimmune diseases, fibrosis, pulmonary disease and cancer/cancer supportive care, in addition to several other clinical indications. Biomodels specializes in (non-GLP) efficacy studies that optimize dose, schedule, and define mechanism of action. Additionally, Biomodels' state of the art Germ-Free and Gnotobiotic animal facility allows for the analysis of the role of the microbiota both in disease pathogenesis and in therapeutic efficacy.
Biomodels, LLC
Biomodels, is an AAALAC accredited preclinical CRO that develops and executes predictive and highly translational efficacy studies for biotech and pharma companies in a variety of indications.
